The acquisition of Alexis will lead to expansion of the company’s footprint in Western India. Alexis being a running hospital, will add revenue and
profitability to the company.Alexis hospital has a revenue of Rs 150 crore and an EBITDA of 25 crore.
The 200 bedded hospital owned and operated by Alexis is a JCI (Joint Commission of US) accredited facility located on a land parcel of 2 acres at Mankapur, an upmarket residential and commercial hub of Nagpur, has the potential to expand upto 340 beds.
The hospital has a built up area of 2.25 lakh sft and offers multidisciplinary care in the areas of gastroenterology, neurosurgery, cardiology, transplants, related diagnostic facilities etc. The hospital is equipped with high end bio medical equipment like Varian TrueBeam LINAC, 128 Slice CT Scan, 3 Tesla MRI, Digital X Ray, ARTIS Q Cath Lab, etc.
Further, the hospital medical program can be further strengthened in the surgical specialties like cardiothoracic and vascular surgery (CTVS), urology, oncology and neurosciences leading to improvement in average revenue per occupied bed (ARPOB) and occupied bed days (OBD).
Nagpur is a fast growing city with a population density of 47 lakh and is strategically located in the heart of Maharashtra and serves adjacent regions like Amravati , Jalgaon, Gondia, Chhindwara, among others. Further the city has availability of experienced medical talent owing to the presence of government hospitals, medical colleges and private healthcare players.
“The acquisition of Alexis Hospital is in line with our vision to expand our footprint in tier 2 cities with abundance of clinical talent and developed private healthcare infrastructure,” said Abhay Soi, chairman and managing director, Max Healthcare.
“Alexis Hospital acquisition will strengthen our presence in the Maharashtra region. With this addition, we now have 4 JCI accredited facilities in our network and we look forward to bringing the high-end quality care to people of the region,” Soi added.
“While we have built a world-class hospital facility, at par with the best, in infrastructure, technology, and clinical services, our decision to consider divesting this business has been driven by our strategic focus on our healthcare businesses in the UAE and Gulf,” said Zanubia Shams, co-chairperson and promoter of Zulekha Healthcare Group that owns Alexis.
Shares of Max Healthcare declined 0.32% and were trading at Rs 867.25 on BSE at 11.15 am on Friday.
(You can now subscribe to our Economic Times WhatsApp channel)
